J 267 J 267 Pill - blue & orange capsule/oblong
Pill with imprint J 267 J 267 is Blue & Orange, Capsule/Oblong and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Jubilant Cadista Pharmaceuticals Inc.
Mycophenolate mofetil is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 267 J 267
Mycophenolate Mofetil
- Imprint
- J 267 J 267
- Strength
- 250 mg
- Color
- Blue & Orange
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jubilant Cadista Pharmaceuticals Inc.
- National Drug Code (NDC)
- 59746-0267
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone k90,
corn starch,
FD&C Blue No. 2,
gelatin,
ferric oxide red,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide yellow,
shellac,
propylene glycol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (61)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Tablets
- Mycophenolate Mofetil Capsules
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
